Alexandria Real Estate Equities, Inc.'s Form 4 filing
Applied Therapeutics, Inc. (APLT) · filed Nov 6, 2023
- Accession no.
- 0001035443-23-000315
- Filed
- Nov 6, 2023, 4:56 PM ET
- Trade date
- Nov 2-3, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $572.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Alexandria Real Estate Equities, Inc.CIK 0001035443 | 10% Owner |
| Alexandria Venture Investments, LLCCIK 0001722024 | 10% Owner |
| Alexandria Equities No. 7, LLCCIK 0001776437 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. The shares were sold at prices ranging from $2.30 to $2.39. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. The shares were sold at prices ranging from $2.25 to $2.38. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.